Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors.
Related Research units
Abstract
A previous study identified midkine (MK) expression in primary gastrointestinal stromal tumor (GIST) as a prognostic marker. The aim of the current study was to compare serum midkine (S-MK) concentrations of GIST patients with those of healthy controls and to determine if MK can serve as a prognostic serum marker for these patients.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 2 |
| ISSN | 1068-9265 |
| Publication status | Published - 2011 |
| pubmed | 20589434 |
|---|
